In vitro synthesis of thymosin beta 4 encoded by rat spleen mRNA.
Filipowicz. A W AW; Horecker. B L BL
Key Findings
- Thymosin‑beta‑4 can be synthesized in vitro using rabbit reticulocyte, yeast, or wheat‑germ extracts
- The produced peptide matches natural beta‑4 by several lab methods, though the wheat‑germ version may lack an acetyl group
- The mRNA for beta‑4 is a small 7‑8S species, and no larger precursor protein was detected
Practical Outcomes
- This study mainly proves the peptide can be produced in lab settings; it doesn’t provide actionable protocols, dosage guidance, or health benefits for personal use.
Summary
Scientists showed they can make the 43‑amino‑acid peptide thymosin‑beta‑4 in test‑tube systems using rat spleen RNA, confirming its exact structure but not revealing any new health effects or dosing tips.
Abstract
Thymosin beta 4, containing 43 amino acids and acetylated at the NH2 terminus, is synthesized in vitro in a rabbit reticulocyte lysate or in a yeast protein-synthesis system in the presence of mRNA from rat spleen. The product formed was identified as beta 4 by immunoprecipitation by a specific anti-beta 4 antiserum, comigration with authentic beta 4 in NaDodSO4/polyacrylamide gel electrophoresis and in HPLC, and identity of peptide fragments. The immunoprecipitable product generated in the wheat germ protein-synthesizing system emerged slightly ahead of beta 4 in HPLC and appeared to lack the NH2-terminal acetyl group. There was no evidence for formation of a larger polypeptide precursor of beta 4 in any of the three systems used. In sucrose density gradient centrifugation, the mRNA coding for beta 4 was recovered in the 7-8S mRNA fraction.
Study Information
pubmed
1983
10.1073/pnas.80.7.1811